Position in PTGX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$10,012,702
+$1,003,637 QoQ
Shares Held
81,683
-4.4% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#76
of 341 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 77%
Shared 0%
None 23%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AXIOM INVESTORS LLC /DE holds $39,098,778 across 6 Biotechnology names. PTGX ranks #1 (25.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTGX |
Protagonist Therapeutics, Inc
This page
|
81,683 | $10,012,702 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
86,880 | $9,646,286 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
108,238 | $6,533,245 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
76,148 | $5,671,503 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
22,631 | $5,539,389 | |
| 6 | VOR |
Vor Biopharma Inc.
|
92,105 | $1,695,653 |
All Filings in PTGX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,012,702 | 81,683 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $9,009,065 | 85,475 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $7,814,135 | 89,468 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $5,321,906 | 80,113 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,831,647 | 51,233 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,932,900 | 39,969 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||